Similar phenomena were also observed in patients with grade IV or glioblastoma (P = 0.032), patients with ATRX loss glioma (P = 0.002), patients without radiotherapy (P = 0.015), or patients without chemotherapy (P = 0.040). Here, ATRX is linked to central nervous system cancer.